XSHE
002870
Market cap661mUSD
Dec 05, Last price
35.41CNY
1D
1.58%
1Q
1.75%
IPO
9.39%
Name
Guangdong Senssun Weighing Apparatus Group Ltd
Chart & Performance
P/E
30.12
P/S
0.79
EPS
1.18
Div Yield, %
0.28%
Shrs. gr., 5y
3.60%
Rev. gr., 5y
47.63%
Revenues
5.90b
+1.97%
Net income
155m
-3.67%
CFO
713m
-15.75%
Dividend
Jun 06, 20240.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangdong Senssun Weighing Apparatus Group Ltd. manufactures health measurement and management solutions primarily in China. The company offers household health products, such as human health, fat, kitchen, electronic table, weight counting, cashier, traceability table, and spring dial scales, as well as other commercial weighing products. It also provides smart measurement products, including smart body fat scales, smart food nutrition scales, smart bracelets, smart baby scales, and smart coasters. The company offers its household weighing instruments for household users; and commercial measurement professional products and technical solutions for commercial users primarily under the Xiangshan, SENSSUN, CAMRY, Golden Leaf, Kangmei, iFit, etc. brands. It also exports its products to approximately 80 countries and regions on five continents worldwide. The company was formerly known as Senssun Weighing Apparatus Co., Ltd. and changed its name to Guangdong Senssun Weighing Apparatus Group Ltd. in January 2008. Guangdong Senssun Weighing Apparatus Group Ltd. was founded in 1975 and is based in Zhongshan, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||